Latest Regional Performance News

Centuria Office REIT delivered a $55.2 million statutory profit in FY26 and near-record leasing, but its FY27 distribution guidance falls below this year’s payout. The balance sheet is stronger after a $1 billion refinancing, leaving occupancy and rental growth as the key tests ahead.

Corporate Travel Management (ASX:CTD) has posted a $17.7 million net profit for FY26, reversing a prior $348.5 million loss, supported by UK client settlements, new debt facilities, and a governance uplift program.

Frontier Digital Ventures narrowed its focus to core classifieds, resulting in a 27% revenue decline but an 18% rise in EBITDA and a $2.5 million profit in the first half of 2026.

Genetic Signatures narrowed its FY2026 net loss by 30% to $14 million amid a strategic overhaul, signing a key 10-year supply deal with Denmark’s Hvidovre Hospital and resetting its US market approach.

Austin Engineering's FY26 results reveal a 12.7% revenue drop and a 53.7% EBITDA decline, driven by operational setbacks in the Americas and a loss-making Chile contract. Improved cash flow and safety metrics offer a silver lining as the company embarks on a reset for FY27.

SiteMinder Limited (ASX:SDR) nearly doubled its adjusted EBITDA to $28.1 million in FY26, driven by a 22% revenue increase and strong adoption of its AI-powered Smart Platform. The company narrowed its net loss by more than half amid ongoing investments in growth and operational efficiency.

Reece Limited posted a 4.5% revenue increase to $9.38 billion in FY26, driven by a strong ANZ recovery and tempered by ongoing challenges in the US residential market. Despite flat EBITDA and a slight dip in net profit, the company unveiled a revamped long-term executive remuneration plan aligned with its 2030 strategy.

Servcorp Limited delivered a record FY26 with a 24% rise in underlying NPBIT to $87 million, boosted dividends by 14%, and outlined a cautious yet optimistic FY27 growth strategy.

Vita Life Sciences delivered a robust first half in 2026 with revenue up 6.1% to A$48.3 million and net profit after tax rising 14.9% to A$5.54 million. The company declared a higher interim dividend, reflecting improved margins and regional market momentum.

Resmed delivered a strong FY2026 with 10% revenue growth to $5.7 billion, a 17% rise in non-GAAP EPS, and a 10% dividend hike. Strategic moves include selling MatrixCare and acquiring Noctrix Health.

GALE Pacific reported a robust $4.1 million operating cash inflow in Q4 FY26, culminating in $14.4 million for the full year. The company reduced borrowings by over $12 million, entering FY27 with a net cash position of $4.9 million and renewed focus on growth amid geopolitical uncertainties.

Love Group Global Ltd (ASX:LVE) reported a record net operating cash flow of $974k for FY26, a 49% increase despite a 13% decline in customer cash receipts. The company plans to grow its matchmaking business in Asia and test expansion into the US and UK.